Skip to main content
. 2019 Oct 2;8(20):e013043. doi: 10.1161/JAHA.119.013043

Table 1.

Demographic and Clinical Characteristics of the Overall Sample and Stratified by the Presence of CMRs and CBVD

 Characteristics Overall (N=1654) Reference (n=594) CMR or CBVD (n=1060) P Valuea CMR (n=828) CBVD (n=232) P Valueb
Age, y 47.5 (12.3) 43.4 (14.0) 53.1 (9.5) <0.01 52.7 (9.3) 54.2 (10.4) <0.01
Men, % 47.5 42.5 54.4 <0.01 52.0 61.3 <0.01
White, % 89.8 91.2 88.0 0.03 86.9 91.5 0.02
Education, y 13.6 (2.8) 14.0 (3.4) 13.2 (2.4) <0.01 13.2 (2.4) 13.2 (2.2) <0.01
BMI, kg/m2 27.6 (5.8) 26.1 (6.1) 29.8 (5.1) <0.01 29.9 (5.1) 29.5 (4.9) <0.01
CMR or CBVD, %
Hypertension 32.9 0.0 78.4 85.7 56.4
Diabetes mellitus 13.9 0.0 33.0 34.0 29.8
Heart disease 9.2 0.0 21.9 0.0 87.9
Stroke 1.6 0.0 3.7 0.0 15.1
Smoker, % 23.7 23.5 24.1 0.78 24.0 24.3 0.96
Alcohol use, drinks/d 1.1 (5.5) 1.3 (8.7) 0.9 (2.0) 0.15 0.9 (2.0) 0.8 (1.9) 0.30
Physical health conditions, % 54.3 52.2 57.3 0.03 55.6 62.6 0.03
Mental health conditions, % 22.5 20.5 25.4 0.02 23.8 30.3 0.01
AHI, events/h 2.3 (7.5) 1.2 (6.4) 3.8 (7.9) <0.01 3.6 (7.6) 4.5 (8.8) <0.01
OSA, % 10.6 6.2 16.6 <0.01 15.9 18.7 <0.01
Objective sleep duration, h 5.9 (1.2) 6.2 (1.4) 5.6 (1.0) <0.01 5.6 (0.9) 5.7 (1.1) <0.01
<6 h, % 44.1 33.6 54.9 <0.01 57.0 48.8 <0.01
Total deaths, % 30.9 16.2 39.2 <0.01 35.1 53.9 <0.01
CBVD cause, % 12.6 5.7 16.5 <0.01 12.8 29.7 <0.01
Non‐CBVD cause, % 18.3 10.4 22.7 <0.01 22.3 24.1 <0.01
Cancer cause, % 7.9 5.7 9.2 0.01 9.2 9.1 0.03
Other causes, % 10.4 4.7 13.6 <0.01 13.2 15.1 <0.01
Survival time, y 19.2 (5.2) 20.5 (3.9) 18.5 (5.7) <0.01 19.1 (5.4) 16.7 (6.4) <0.01
Alive, y 21.6 (2.3) 21.5 (2.3) 21.6 (2.3) 0.55 21.7 (2.3) 21.4 (2.1) 0.51
Deceased, y 14.0 (6.0) 14.9 (5.6) 13.8 (6.0) 0.09 14.2 (6.0) 12.4 (6.0) 0.01

Data are mean (SD) for continuous variables and percentage for binary variables. The reference group was absent of CMR and CBVD. AHI indicates apnea‐hypopnea index; BMI, body mass index; CBVD, cardiovascular and cerebrovascular disease (ie, heart disease and/or stroke); CMR, cardiometabolic risk factor (ie, hypertension and/or diabetes mellitus); OSA, obstructive sleep apnea (ie, AHI ≥5 events per hour of sleep).

a

P value comparing reference vs CMR or CBVD (t‐test and χ2 test were used to compare continuous and binary variables, respectively)

b

P value comparing reference vs CMR vs CBVD (ANOVA or Cochran‐Mantel‐Haenszel test was used to compare continuous and binary variables among the 3 groups, respectively).